Engineering the innate immune response to Staphaureus infection
Engineering the innate immune response to Staphaureus infection
批准号:
9401775
负责人:
J. Kent Leach
金额:
$38.07万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2022-06-30
关键词:
AcuteAnimalsAnti-Bacterial AgentsAntibiotic ResistanceBacteriaBacterial AntigensBiological Response Modifier TherapyBioreactorsBone MarrowCD34 geneCell CommunicationCell Differentiation processCell TherapyCell WallCellsChimera organismCommunitiesComplicationCutaneousDataDetectionEngineeringGenerationsGenetic EngineeringGoalsGranulopoiesisHematopoietic stem cellsHemolysinHospitalsHost DefenseHumanHybridsImmuneImmune responseImmune signalingImmunodeficient MouseImmunofluorescence ImmunologicImmunosuppressionImpaired wound healingIn VitroInfectionInflammasomeInflammationInnate Immune ResponseKnock-in MouseKnowledgeLeadLeukocytesMesenchymal Stem CellsMethicillin ResistanceMicrofluidicsModelingMonitorMulti-Drug ResistanceMuramidaseMusMyelogenousMyeloid Progenitor CellsNeutrophil InfiltrationOrganPeptidoglycanProcessRecruitment ActivityResolutionRoleSignal TransductionSiteSkin TissueSkin woundSoft Tissue InfectionsSourceStaphylococcus aureusStem cellsTLR2 geneTestingTherapeuticTissuesToxinTransgenic OrganismsVirulenceVirulence FactorsVirulentWound HealingWound Infectionalpha Toxinbactericidecellular engineeringchronic woundcombatenhancing factorhealingimaging approachimmune functionimmunoregulationimprovedin vivoinnovationmacrophagemethicillin resistant Staphylococcus aureusmicrobialneutrophilnew technologynovelnovel therapeuticsoptical imagingpathogenpreventprogenitorresistant strainresponsetraitwound
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Staphylococcus aureus (SA) is a major cause of cutaneous infections. Virulent
community-acquired methicillin-resistant SA (MRSA) is the most common source of skin
and soft tissue infections in U.S. hospitals. Prompt recruitment of polymorphonuclear
(PMN) leukocytes in sufficient numbers to the site of infection is critical for controlling
MRSA infection and preventing dissemination to vital organs. Unexpectedly, we recently
discovered that hematopoietic stem and progenitor cells (HSPCs) are also recruited to
wounds, and these cells detect bacterial antigens and virulence factors, and augment
PMN numbers necessary to resolve a MRSA infected wound. The signaling process
eliciting an increase in myeloid recruitment and differentiation of HSPC within the wound
was found to involve toll-like receptor 2 (TLR2) detection of peptidoglycans derived from
the gram-positive cell wall and released within the wound. We propose that this newly
discovered host immune trait is an adaption to effectively overcome immune
suppression by MRSA virulence factors such as α-hemolysin toxin (AT) that blocks PMN
recruitment by lysing perivascular macrophages that help guide them to sites of
infection. The central hypothesis governing this proposal is that immune-modulation that
tunes PMN number and antibacterial activity against MRSA infection can hasten
clearance and healing. This proposal will utilize our innovative model of wound infection
that employs genetically-engineered bioluminescent bacteria and a transgenic lysozyme-
M-EGFP knock-in mouse that produces fluorescent mature PMN. This model will be
used in conjunction with advanced in vivo whole animal optical imaging to noninvasively
and longitudinally monitor bacterial burden and immune responses. A translational goal
will be the implementation of human CD34+ HSPC myeloid expansion to evaluate the
therapeutic potential of local PMN expansion to combat MRSA infection in an
immunodeficient (NSG) mouse wound model.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MUSCLE: MUsculoSkeletal Clinical Learning Experience Transdisciplinary Musculoskeletal Research Training Program
-
批准号:10410848
-
项目类别:
-
资助金额:$17.98万
-
财政年份:2022
-
负责人:J. Kent Leach
-
依托单位:
ORS-ISFR 17th International Biennial Meeting
-
批准号:10540642
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2022
-
负责人:J. Kent Leach
-
依托单位:
MUSCLE: MUsculoSkeletal Clinical Learning Experience Transdisciplinary Musculoskeletal Research Training Program
-
批准号:10612446
-
项目类别:
-
资助金额:$18.36万
-
财政年份:2022
-
负责人:J. Kent Leach
-
依托单位:
Identifying the superior ossification pathway for tissue engineered approaches to long bone repair
-
批准号:10230915
-
项目类别:
-
资助金额:$43.37万
-
财政年份:2021
-
负责人:J. Kent Leach
-
依托单位:
Identifying the superior ossification pathway for tissue engineered approaches to long bone repair
-
批准号:10591573
-
项目类别:
-
资助金额:$37.99万
-
财政年份:2021
-
负责人:J. Kent Leach
-
依托单位:
Identifying the superior ossification pathway for tissue engineered approaches to long bone repair
-
批准号:10376368
-
项目类别:
-
资助金额:$37.61万
-
财政年份:2021
-
负责人:J. Kent Leach
-
依托单位:
Dual peptide presentation from bioengineered carriers to potentiate stromal cell function and tissue repair
-
批准号:9320107
-
项目类别:
-
资助金额:$45.33万
-
财政年份:2017
-
负责人:J. Kent Leach
-
依托单位:
Dual peptide presentation from bioengineered carriers to potentiate stromal cell function and tissue repair
-
批准号:9883782
-
项目类别:
-
资助金额:$45.4万
-
财政年份:2017
-
负责人:J. Kent Leach
-
依托单位:
Engineering the innate immune response to Staphaureus infection
-
批准号:10212940
-
项目类别:
-
资助金额:$37.81万
-
财政年份:2017
-
负责人:J. Kent Leach
-
依托单位:
Dual peptide presentation from bioengineered carriers to potentiate stromal cell function and tissue repair
-
批准号:9930177
-
项目类别:
-
资助金额:$21.56万
-
财政年份:2017
-
负责人:J. Kent Leach
-
依托单位:
Engineering the innate immune response to Staphaureus infection
-
批准号:9980775
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2017
-
负责人:J. Kent Leach
-
依托单位:
Biomaterial regulation of cell spheroids to synergistically enhance bone healing
-
批准号:8968201
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2015
-
负责人:J. Kent Leach
-
依托单位:
Cell delivery for irradiated bone defects
-
批准号:8231275
-
项目类别:
-
资助金额:$11.54万
-
财政年份:2011
-
负责人:J. Kent Leach
-
依托单位:
Cell delivery for irradiated bone defects
-
批准号:8090169
-
项目类别:
-
资助金额:$11.5万
-
财政年份:2011
-
负责人:J. Kent Leach
-
依托单位:
Phospholipids for enhancing cell-based neovascularization
-
批准号:7990390
-
项目类别:
-
资助金额:$18.82万
-
财政年份:2010
-
负责人:J. Kent Leach
-
依托单位:
Phospholipids for enhancing cell-based neovascularization
-
批准号:8097948
-
项目类别:
-
资助金额:$15.12万
-
财政年份:2010
-
负责人:J. Kent Leach
-
依托单位:
海外基金